4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-22-001495
Chief Executive Officer acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Climaco John M · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-07 | Grant or award : show line 1 in the form | +35,000 | $0.28 | $9,835 | 940,298 | D |
Loading xslF345X03/ownership.xml…